Panayiotis Tsaftaridis

Statistics

Publications

Citations

323

H-Index

Active since

1993

Affiliations

National and Kapodistrian University of Athens(Current)

Laiko General Hospital of Athens

Athens Medical Center

Panayiotis Tsaftaridis is an author at National and Kapodistrian University of Athens specializing in medicine, oncology, and hematologic malignancy therapy.

Publications per year

1993–2022

Publications

Treatment of Splenic Marginal Zone Lymphoma With Rituximab Monotherapy: Progress Report and Comparison With Splenectomy

Christina Kalpadakis, Gerassimos A. Pangalis, Maria K. Angelopoulou et al. · The Oncologist · 2013 · 89 citations · Full text

Medicine, Oncology, Pharmacotherapy +11

The prognostic significance of beta(2)-microglobulin in patients with Hodgkin's lymphoma.

Theodoros P. Vassilakopoulos, Gianpaolo Nadali, Maria K. Angelopoulou et al. · PubMed · 2002 · 49 citations

Medicine, Hematology, Oncology +16

Serum levels of soluble syndecan-1 in Hodgkin's lymphoma.

Theodoros P. Vassilakopoulos, Marie‐Christine Kyrtsonis, Argiroula Papadogiannis et al. · PubMed · 2006 · 29 citations

Medicine, Oncology, Pathology +12

Downstaging Rai stage III B-chronic lymphocytic leukemia patients with the administration of recombinant human erythropoietin.

Gerassimos A. Pangalis, Marina P. Siakantaris, Maria K. Angelopoulou et al. · PubMed · 2002 · 27 citations

Medicine, Hematology, Pharmacotherapy +16

Prognostic Implication of the Absolute Lymphocyte to Absolute Monocyte Count Ratio in Patients With Classical Hodgkin Lymphoma Treated With Doxorubicin, Bleomycin, Vinblastine, and Dacarbazine or Equivalent Regimens

Theodoros P. Vassilakopoulos, Maria Dimopoulou, Maria K. Angelopoulou et al. · The Oncologist · 2016 · 26 citations · Full text

Medicine, Hematology, Oncology +12

1–5 of 11